Hydronephrosis

Last updated: February 23, 2023

Hydronephrosis

IM EOR

IM EOR

Angina pectoris
Premature atrial contraction
Premature ventricular contraction
Supraventricular arrhythmias: Pathology review
Ventricular tachycardia
Ventricular fibrillation
Atrial flutter
Atrial fibrillation
Wolff-Parkinson-White syndrome
Atrioventricular nodal reentrant tachycardia (AVNRT)
Long QT syndrome and Torsade de pointes
Stable angina
Unstable angina
Prinzmetal angina
Class I antiarrhythmics: Sodium channel blockers
Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Restrictive cardiomyopathy
Heart failure
Diabetes mellitus
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Insulins
Diabetes insipidus
Hypercalcemia
Hypocalcemia
Hypernatremia
Hyponatremia
Hyperparathyroidism
Hypoparathyroidism
Hypercholesterolemia: Clinical
Lipid-lowering medications: Statins
Coronary artery disease: Clinical
Endocarditis
Class II antiarrhythmics: Beta blockers
Peptic ulcer
Acute pancreatitis
Chronic pancreatitis
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Gastritis
Thiazide and thiazide-like diuretics
ACE inhibitors, ARBs and direct renin inhibitors
ECG cardiac infarction and ischemia
Abnormal heart sounds
Pulmonary valve disease
Tricuspid valve disease
cGMP mediated smooth muscle vasodilators
Sarcoidosis
Mycobacterium tuberculosis (Tuberculosis)
Pneumonia
Myocardial infarction
Adrenergic antagonists: Beta blockers
Hyperthyroidism
Hypothyroidism
Thyroid storm
Hypertension: Clinical
Class IV antiarrhythmics: Calcium channel blockers and others
Calcium channel blockers
Asthma
Emphysema
Pericarditis and pericardial effusion
Cardiac tamponade
Antiplatelet medications
Primary adrenal insufficiency
Pheochromocytoma
Cushing syndrome
Ischemic stroke
Bell palsy
Multiple sclerosis
Guillain-Barre syndrome
Bundle branch block
Migraine
Tension headache
Cluster headache
Syncope: Clinical
Transient ischemic attack
Non-steroidal anti-inflammatory drugs
Fibromyalgia
Gout
Systemic lupus erythematosus
Iron deficiency anemia
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Pulmonary hypertension
Pneumothorax
Lung cancer
Pulmonary embolism
Pseudomonas aeruginosa
Clostridium botulinum (Botulism)
Vitamin B12 deficiency
Influenza virus
Sickle cell disease (NORD)
Treponema pallidum (Syphilis)
Clostridium tetani (Tetanus)
Borrelia burgdorferi (Lyme disease)
Protein C deficiency
Folate (Vitamin B9) deficiency
Factor V Leiden
Protein S deficiency
Antithrombin III deficiency
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Paget disease of bone
Antiphospholipid syndrome
Rheumatoid arthritis
Ulcerative colitis
Candida
Cryptococcus neoformans
Positive and negative predictive value
Cirrhosis
Thyroid cancer
Shock
Neisseria gonorrhoeae
Pituitary adenoma
Seizures and epilepsy
Bordetella pertussis (Whooping cough)
Prostatitis
Meningitis
Vibrio cholerae (Cholera)
Testicular torsion
Epididymitis
Polycystic kidney disease
Polymyalgia rheumatica
Polymyositis
Hemorrhoid
Portal hypertension
Varicocele
Varicella zoster virus
Irritable bowel syndrome
Cytomegalovirus
Acid reducing medications
Concussion and traumatic brain injury
Hepatocellular carcinoma
Renal artery stenosis
Rheumatic heart disease
Cor pulmonale
Gastroesophageal reflux disease (GERD)
Sjogren syndrome
Huntington disease
Scleroderma
Acute cholecystitis
Viral hepatitis
Appendicitis
Diverticulosis and diverticulitis
Kidney stones
Acute pyelonephritis
Chronic pyelonephritis
Lower urinary tract infection
Glaucoma
Ascending cholangitis
Non-urothelial bladder cancers
Hydronephrosis
Celiac disease
Benign prostatic hyperplasia
Prerenal azotemia
Renal azotemia
Postrenal azotemia
Chronic kidney disease
Poststreptococcal glomerulonephritis
Membranous nephropathy
Membranoproliferative glomerulonephritis
IgA nephropathy (NORD)
Acute tubular necrosis
Acute kidney injury: Clinical
Chronic kidney disease: Clinical
Alport syndrome
Parkinson disease
Encephalitis
Delirium
Dementia with Lewy bodies
Vascular dementia
Frontotemporal dementia
Alzheimer disease
Adult brain tumors
Acid-base map and compensatory mechanisms
Erectile dysfunction
Acromegaly
Esophageal web
Esophageal disorders: Clinical
Colorectal cancer
Rapidly progressive glomerulonephritis
Goodpasture syndrome
Esophageal cancer
Gastric cancer
Esophagitis: Clinical
HIV (AIDS)
Anemia of chronic disease
Beta-thalassemia
Anemia of chronic disease
Alpha-thalassemia
Multiple myeloma
Shigella
Toxoplasma gondii (Toxoplasmosis)
Histoplasmosis
Rickettsia rickettsii (Rocky Mountain spotted fever) and other Rickettsia species
Pneumonia: Clinical

Transcript

Watch video only

Content Reviewers

With hydronephrosis, -hydro means water, -nephro means kidneys, and -osis refers to a disease state, so hydronephrosis refers a disease or condition where excessive amounts of water, in the form of urine, causes the kidneys to dilate.

Now, normally, inside the kidneys, urine forms in the nephron and then drains through the papilla which is an inverted cone shaped pyramid, that, like a shower head, pours urine into the calyces, which comes from the latin -calix which means large cup, like a Roman chalice.

From there it enters the renal pelvis which funnels the urine into the ureter.

If there’s an obstruction to this normal flow of urine, then it can cause urinary pressures to increase and push out on the walls of these structures making them dilate. This might happen because of something within the urinary tract,for example, a kidney stone, or from external compression, for example, when a fetus pushes up against the urinary tract during pregnancy.

Typically the dilation starts closest to the site of the problem and then slowly continues back up towards the kidneys.

Now, if there’s dilation of just the ureter, it’s called hydroureter, but if there’s dilation of the ureter, renal pelvis, and the calyces, it’s called hydroureteronephrosis or more commonly just hydronephrosis.

The causes of hydronephrosis differ by age group.

Hydronephrosis in the fetus is called antenatal hydronephrosis, and sometimes the cause here is unknown, and it develops and disappears on its own, so it may be a variation of normal development. But if hydronephrosis progresses through fetal development into the third trimester, then there may be an actual underlying pathology. For example, there’s congenital ureteropelvic junction obstruction, which is where the ureteropelvic junction—which connects the ureter to the kidney—fails to canalize during development, which can obstruct the flow of urine.

Another cause is vesicoureteral reflux which is where urine is allowed to backflow from the bladder into the ureters and eventually kidneys.

In young children, hydronephrosis usually results from a congenital malformation like a ureterocele, which is a sac of tissue in the distal ureter, that also obstructs the flow of urine from the ureter into the bladder, as well as posterior urethral valves, which is a malformation of the posterior urethra where flaps of tissue obstruct the outflow of urine.

In contrast, adults with hydronephrosis usually develop it as a result of an acquired disease, like kidney stones, which is the most common cause, as well as prostatic hyperplasia, or enlarged prostate, which blocks the flow of urine out of the bladder.

Now, severe long-standing hydronephrosis can lead to nephron destruction and can result in an increase in serum creatinine, as well as electrolyte imbalances. When this sort of damage has happened, the kidney can develop a dilated ureter and renal pelvis, as well as compression atrophy, which is thinning of the renal medulla and cortex.

Symptoms and complications of hydronephrosis are often related to symptoms of obstruction, since that’s the context in which hydronephrosis is usually found.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Hydronephrosis in the course of ureteropelvic junction obstruction - an underestimated problem?Current opinion on pathogenesis, diagnosis and treatment." Advances in Clinical and Experimental Medicine (2017)
  6. "Congenital Anomalies of Kidney and Urinary Tract" Seminars in Nephrology (2010)
  7. "Prenatal hydronephrosis: early evaluation" Current Opinion in Urology (2008)